Skip to content. Skip to navigation
Personal tools
  Members Area  

ANZCA

Sections
You are here: Home → Events → ANZCA Annual Scientific Meetings → 2008 ASM → Scientific Program → PBLD / Quality Assurance Sessions
Navigation
News
02-09-2008
September 2008 Trial Resource
Online trial
More
28-08-2008
August 2008
More
24-08-2008
New drug
A new drug has just been approved for use in Australia. SITAGLIPTIN (Januvia) is an oral drug for type 2 Diabetes mellitus. It is a new class of drug, a dipeptidyl peptidase (DPP-4) inhibitor. Sitagliptin is an 'incretin enhancer' that increases the levels of active incretin by inhibiting their metabolism by DPP-4, thus prolonging their effect in stimulating insulin release and decreasing glucagon secretion.
More
24-08-2008
Latest ANZCA e-newsletter online
The latest edition of ANZCA’s e-newsletter has now been emailed to Fellows, trainees and ANZCA staff.
More
21-08-2008
Fellowship Affairs
The first meeting of the Fellowship Affairs Committee was held on Friday, 15 August 2008. Chaired by Dr Margaret Cowling, the Committee oversees all matters directly pertinent to Fellows, including CPD, annual scientific meetings, Regional CME and SIG events, communications and professional issues
More
More news…
 
Document Actions

PBLD / Quality Assurance Sessions

Click here to get the file

Size 54.8 kB - File type application/pdf